We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 3,176

Inherent Obviousness: Available IPR Rationale With a High Standard
  • Jones Day
  • USA
  • December 8 2017

On November 28, 2017, the PTAB issued a final written decision upholding the patentability of U.S. Patent No. 6,667,061 (IPR2016-01096). The '061

Patentability in Japan
  • SUGIMURA & Partners
  • Global, Japan
  • November 17 2017

A structured guide to patents law and practice in Japan

CMS Finalizes Changes in CY 2018 OPPS and PFS Final Rules
  • K&L Gates
  • USA
  • November 7 2017

On November 1, 2017, the Centers for Medicare & Medicaid Services (“CMS”) released its final rule with comment period revising the Medicare Hospital

Final CMS Rules Draw Praise and Contempt from Hospitals
  • Frost Brown Todd LLC
  • USA
  • November 7 2017

As usual, this year CMS did not disappoint, having just issued several final rules for the Physician Fee Schedule (PFS), as well as the Outpatient

Connecticut Implements End-of-Life Program
  • Day Pitney LLP
  • USA
  • October 13 2017

On October 4, the Connecticut Department of Public Health (DPH) announced the implementation of a statewide program that gives patients the ability to

Clinical trials in Switzerland
  • Bär & Karrer
  • Switzerland, Global
  • October 11 2017

A structured guide to clinical trials in Switzerland

Life sciences: product regulation and liability in the USA
  • Perkins Coie LLP
  • USA, Global
  • October 11 2017

A structured guide to product regulation and liability in the USA

Small Community Pharmacy Hits Walgreens and Prime Therapeutics with $1.5 Billion Antitrust Suit
  • Duane Morris LLP
  • USA
  • September 26 2017

On September 21, 2017, J&S Community Pharmacy, Inc., a neighborhood pharmacy in Chicago alleges Walgreens and Prime Therapeutics worked together to

Patents in France
  • Casalonga & Associés
  • France, Global
  • September 22 2017

A structured guide to patents law and practice in France

California Governor Considers Drug Price Reporting Bill and Ban on Discounts and Rebates for Branded Pharmaceutical Products
  • Cooley LLP
  • USA
  • September 18 2017

The California State Legislature sent two new pharmaceutical pricing measures, S.B. 17 and A.B. 265, to Governor Jerry Brown on September 13th. S.B